[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

DK3217964T3 - Sammensætning - Google Patents

Sammensætning Download PDF

Info

Publication number
DK3217964T3
DK3217964T3 DK15797173T DK15797173T DK3217964T3 DK 3217964 T3 DK3217964 T3 DK 3217964T3 DK 15797173 T DK15797173 T DK 15797173T DK 15797173 T DK15797173 T DK 15797173T DK 3217964 T3 DK3217964 T3 DK 3217964T3
Authority
DK
Denmark
Prior art keywords
composition
Prior art date
Application number
DK15797173T
Other languages
English (en)
Inventor
Howard Norman Ernest Stevens
Alexander Balfour Mullen
David Smith
Fiona Jane Macdougall
Vivekanand Bhardwaj
Original Assignee
Drug Delivery Int Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Drug Delivery Int Ltd filed Critical Drug Delivery Int Ltd
Application granted granted Critical
Publication of DK3217964T3 publication Critical patent/DK3217964T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/282—Organic compounds, e.g. fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/288—Compounds of unknown constitution, e.g. material from plants or animals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Botany (AREA)
  • Zoology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK15797173T 2014-11-14 2015-11-16 Sammensætning DK3217964T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1420306.1A GB201420306D0 (en) 2014-11-14 2014-11-14 Compositions
PCT/GB2015/053471 WO2016075495A1 (en) 2014-11-14 2015-11-16 Composition

Publications (1)

Publication Number Publication Date
DK3217964T3 true DK3217964T3 (da) 2019-11-25

Family

ID=52248394

Family Applications (1)

Application Number Title Priority Date Filing Date
DK15797173T DK3217964T3 (da) 2014-11-14 2015-11-16 Sammensætning

Country Status (19)

Country Link
US (1) US10675247B2 (da)
EP (1) EP3217964B1 (da)
JP (1) JP6774103B2 (da)
KR (1) KR102253728B1 (da)
CN (1) CN106999438A (da)
AU (1) AU2015344838B2 (da)
CA (1) CA2967738C (da)
DK (1) DK3217964T3 (da)
ES (1) ES2755960T3 (da)
GB (1) GB201420306D0 (da)
HK (1) HK1244432A1 (da)
HU (1) HUE047581T2 (da)
MX (1) MX2017006168A (da)
PL (1) PL3217964T3 (da)
PT (1) PT3217964T (da)
RU (1) RU2717574C2 (da)
SA (1) SA517381522B1 (da)
SI (1) SI3217964T1 (da)
WO (1) WO2016075495A1 (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201420311D0 (en) * 2014-11-14 2014-12-31 Bio Images Drug Delivery Ltd Pharmaceutical processing
CN111698983B (zh) * 2018-01-09 2022-10-18 南京三迭纪医药科技有限公司 一种包含固定剂量adhd非兴奋剂和adhd兴奋剂的复方口服药物剂型
WO2023214280A1 (en) * 2022-05-06 2023-11-09 Craft Health Pte Ltd System for controllable release in 3d-printed colon targeting (corr3ct) oral dosage form

Family Cites Families (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4132753A (en) 1965-02-12 1979-01-02 American Cyanamid Company Process for preparing oral sustained release granules
JPS5839618A (ja) 1981-09-04 1983-03-08 Chugai Pharmaceut Co Ltd 持続性積層錠剤
US4443428A (en) 1982-06-21 1984-04-17 Euroceltique, S.A. Extended action controlled release compositions
US5026560A (en) 1987-01-29 1991-06-25 Takeda Chemical Industries, Ltd. Spherical granules having core and their production
US5126145A (en) 1989-04-13 1992-06-30 Upsher Smith Laboratories Inc Controlled release tablet containing water soluble medicament
EP0418596A3 (en) 1989-09-21 1991-10-23 American Cyanamid Company Controlled release pharmaceutical compositions from spherical granules in tabletted oral dosage unit form
IE61651B1 (en) 1990-07-04 1994-11-16 Zambon Spa Programmed release oral solid pharmaceutical dosage form
AU3949093A (en) 1992-03-31 1993-11-08 Benzon Pharma A/S A pharmaceutical formulation
JP3059004B2 (ja) * 1992-09-18 2000-07-04 ダイセル化学工業株式会社 アルカリ水溶液に対する溶解性の高い低置換度ヒドロキシプロピルセルロース及びその製造法
IL109770A0 (en) 1993-05-29 1994-11-28 Smithkline Beecham Corp Thermal infusion process for preparing controlled release solid dosage forms of medicaments for oral administration and controlled release solid dosage forms of medicaments prepared thereby
US5690959A (en) 1993-05-29 1997-11-25 Smithkline Beecham Corporation Pharmaceutical thermal infusion process
US5451409A (en) * 1993-11-22 1995-09-19 Rencher; William F. Sustained release matrix system using hydroxyethyl cellulose and hydroxypropyl cellulose polymer blends
JPH07223970A (ja) * 1994-02-10 1995-08-22 Tanabe Seiyaku Co Ltd 消化管内適所放出製剤
EP1736144B1 (en) 1998-05-18 2015-11-11 Takeda Pharmaceutical Company Limited Orally disintegrable tablets
AU770645B2 (en) 1998-11-02 2004-02-26 Alkermes Pharma Ireland Limited Multiparticulate modified release composition
US6340478B1 (en) 1999-06-07 2002-01-22 Bio Dar Ltd. Microencapsulated and controlled-release herbal formulations
US6555139B2 (en) 1999-06-28 2003-04-29 Wockhardt Europe Limited Preparation of micron-size pharmaceutical particles by microfluidization
CN1227001C (zh) * 1999-09-10 2005-11-16 兰贝克赛实验室有限公司 依托度酸的缓释制剂
IN190974B (da) 1999-09-10 2003-09-06 Ranbaxy Lab Ltd
CA2389235C (en) 1999-10-29 2007-07-17 Euro-Celtique, S.A. Controlled release hydrocodone formulations
CA2398555C (en) 2000-01-27 2008-04-22 Tanabe Seiyaku Co., Ltd. Sustained release preparation and method for producing the same
JP4817562B2 (ja) * 2001-09-26 2011-11-16 東和薬品株式会社 長時間持続型ニフエジピン有核錠
JP2003171277A (ja) * 2001-12-07 2003-06-17 Wyeth Lederle Japan Ltd 薬物放出時間制御型固形製剤
ES2368066T3 (es) 2003-04-24 2011-11-14 Jagotec Ag Comprimido de liberación retardada con geometría de nucleo definida.
US20040241234A1 (en) 2003-06-02 2004-12-02 Alpharma, Inc. Controlled release press-coated formulations of water-soluble active agents
US6869963B2 (en) * 2003-07-11 2005-03-22 Sandoz Ag Stable pharmaceutical compositions containing an ACE inhibitor
US20050158383A1 (en) 2003-10-21 2005-07-21 Garth Boehm Quetiapine formulations
CA2552064A1 (en) 2003-12-31 2005-07-21 Actavis Group Hf Atomoxetine formulations
US20050220877A1 (en) * 2004-03-31 2005-10-06 Patel Ashish A Bilayer tablet comprising an antihistamine and a decongestant
US20060008527A1 (en) 2004-07-09 2006-01-12 Yury Lagoviyer Controlled phase composition technology as an improved process for protection of drugs
EP1793808A1 (en) 2004-09-29 2007-06-13 Aurobindo Pharma Limited Solid unit dosage forms of 5-ht1 agonist
US20070129402A1 (en) 2004-12-27 2007-06-07 Eisai Research Institute Sustained release formulations
ZA200802602B (en) 2005-08-24 2009-10-28 Rubicon Res Pvt Ltd Controlled release formulation
RU2454225C2 (ru) * 2006-06-01 2012-06-27 Эм Эс Ди Консьюмер Кэар, Инк. Фармацевтические лекарственные формы и композиции фенилэфрина для абсорбции в ободочной кишке
KR100812538B1 (ko) 2006-10-23 2008-03-11 한올제약주식회사 약물 제어방출형 메트포르민-글리메피리드 복합제제
US9833510B2 (en) 2007-06-12 2017-12-05 Johnson & Johnson Consumer Inc. Modified release solid or semi-solid dosage forms
JP5351490B2 (ja) * 2007-10-25 2013-11-27 バイエル薬品株式会社 ニフェジピン含有有核錠剤およびその製法
JP4329947B1 (ja) * 2009-01-20 2009-09-09 ライオン株式会社 内服用錠剤
GB201003731D0 (en) * 2010-03-05 2010-04-21 Univ Strathclyde Immediate/delayed drug delivery
GB201003734D0 (en) * 2010-03-05 2010-04-21 Univ Strathclyde Delayed prolonged drug delivery
GB201003766D0 (en) * 2010-03-05 2010-04-21 Univ Strathclyde Pulsatile drug release
CN103690545A (zh) * 2013-11-27 2014-04-02 河南中帅医药科技股份有限公司 口服泼尼松择时释放制剂及其制备方法
GB201420311D0 (en) 2014-11-14 2014-12-31 Bio Images Drug Delivery Ltd Pharmaceutical processing
GB201420300D0 (en) 2014-11-14 2014-12-31 Bio Images Drug Delivery Ltd Tablet

Also Published As

Publication number Publication date
KR20170084282A (ko) 2017-07-19
JP2017534688A (ja) 2017-11-24
RU2017116588A3 (da) 2019-06-18
WO2016075495A1 (en) 2016-05-19
US20170333355A1 (en) 2017-11-23
CA2967738C (en) 2021-07-06
RU2017116588A (ru) 2018-12-14
KR102253728B1 (ko) 2021-05-21
MX2017006168A (es) 2017-09-12
AU2015344838A1 (en) 2017-06-01
PT3217964T (pt) 2019-11-26
HK1244432A1 (zh) 2018-08-10
PL3217964T3 (pl) 2020-03-31
SA517381522B1 (ar) 2021-04-06
SI3217964T1 (sl) 2020-02-28
EP3217964A1 (en) 2017-09-20
AU2015344838B2 (en) 2020-10-08
ES2755960T3 (es) 2020-04-24
EP3217964B1 (en) 2019-09-04
HUE047581T2 (hu) 2020-05-28
GB201420306D0 (en) 2014-12-31
US10675247B2 (en) 2020-06-09
CA2967738A1 (en) 2016-05-19
RU2717574C2 (ru) 2020-03-24
BR112017010070A2 (pt) 2018-01-02
CN106999438A (zh) 2017-08-01
JP6774103B2 (ja) 2020-10-21

Similar Documents

Publication Publication Date Title
DK3134402T3 (da) 4-amino-imidazoquinolinforbindelser
DK3183051T3 (da) Væske-til-luftmembranenergivekslere
DK3040326T3 (da) Haloolefin-baseret sammensætning
DK3211743T3 (da) Ø-til-netværk-omskiftningsfremgangsmåde
DK3222714T3 (da) Phytasemutanter
DK3215173T3 (da) Glycopeptidsammensætninger
DK3006072T3 (da) Karadgang
DK3119396T3 (da) Muscarinreceptoragonister
FR3024363B1 (fr) Composition thermogelifiable
DE112015001664A5 (de) Betätigungsaktuator
DK3183340T3 (da) Termolabile exonukleaser
CL2017000639A1 (es) Composición
DK3154703T3 (da) Fuldkappe-snekkecentrifuge
DK3110439T3 (da) Pcsk9-vacciner
DE112015005041A5 (de) Gargerätevorrichtung
DK3393254T3 (da) Sammensætning
DK3200827T3 (da) Sammensætninger
DE102014000623A8 (de) Halbhohlnietelement
DK3322295T3 (da) Sammensætning
DK3217964T3 (da) Sammensætning
BR112017016240A2 (pt) composição
DK3009858T3 (da) Skyradar
FR3019552B1 (fr) Composition filmogene
DE112015001633A5 (de) Betätigungsaktuator
DK3447493T3 (da) Proteinrettede ortologer